Table 1. Patient and tumor characteristics for TSCC.
Patient and tumor characteristics | All patients (n = 108) | Patients with R10G (n = 21) | Patients without R10G (n = 87) | Patients with L83V (n = 43) | Patients without L83V (n = 65) | |||||
Gender | n | % | n | % | n | % | n | % | n | % |
Male | 84 | 78% | 17 | 81% | 67 | 77% | 32 | 74% | 52 | 80% |
Female | 24 | 22% | 4 | 19% | 20 | 23% | 11 | 26% | 13 | 20% |
Mean age | 59.7 | 59.4 | 59.8 | 60.1 | 59.8 | |||||
TNM classification | ||||||||||
T1 | 24 | 22% | 6 | 29% | 18 | 21% | 10 | 23% | 14 | 22% |
T2 | 44 | 41% | 10 | 48% | 34 | 39% | 17 | 40% | 27 | 42% |
T3 | 24 | 22% | 3 | 14% | 21 | 24% | 9 | 21% | 15 | 23% |
T4a-b | 16 | 15% | 2 | 10% | 14 | 16% | 7 | 16% | 9 | 14% |
N0 | 17 | 16% | 4 | 19% | 13 | 15% | 5 | 12% | 12 | 18% |
N1 | 26 | 24% | 4 | 19% | 22 | 25% | 14 | 33% | 12 | 18% |
N2a-c | 63 | 58% | 14 | 67% | 49 | 56% | 24 | 56% | 39 | 60% |
N3 | 3 | 3% | 0 | 0% | 3 | 3% | 1 | 2% | 2 | 3% |
M0 | 106 | 98% | 21 | 100% | 85 | 98% | 42 | 98% | 64 | 98% |
M1 | 2 | 2% | 0 | 0% | 2 | 2% | 1 | 2% | 1 | 2% |
Stage | ||||||||||
I | 2 | 2% | 1 | 5% | 1 | 1% | 2 | 5% | 0 | 0% |
II | 7 | 6% | 2 | 10% | 5 | 6% | 2 | 5% | 5 | 8% |
III | 28 | 26% | 5 | 24% | 23 | 26% | 11 | 26% | 17 | 26% |
IV | 72 | 67% | 14 | 67% | 58 | 67% | 29 | 67% | 43 | 66% |